Literature DB >> 8403308

Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure.

M Volpe1, C Tritto, N DeLuca, S Rubattu, M A Rao, F Lamenza, A Mirante, I Enea, V Rendina, A F Mele.   

Abstract

BACKGROUND: Sodium retention and hormonal activation are fundamental hallmarks in congestive heart failure. The present study was designed to assess the ability of patients with asymptomatic to mildly symptomatic heart failure and no signs or symptoms of congestion to excrete ingested sodium and to identify possible early abnormalities of hormonal and hemodynamic mechanisms related to sodium handling. METHODS AND
RESULTS: The effects of a high salt diet (250 mEq/day for 6 days) on hemodynamics, salt-regulating hormones, and renal excretory response were investigated in a balanced study in 12 untreated patients with idiopathic or ischemic dilated cardiomyopathy and mild heart failure (NYHA class I-II, ejection fraction < 50%) (HF) and in 12 normal subjects, who had been previously maintained a 100 mEq/day NaCl diet. In normal subjects, high salt diet was associated with significant increases of echocardiographically measured left ventricular end-diastolic volume, ejection fraction, and stroke volume (all P < .001) and with a reduction of total peripheral resistance (P < .001). In addition, plasma atrial natriuretic factor (ANF) levels increased (P < .05), and plasma renin activity and aldosterone concentrations fell (both P < .001) in normals in response to salt excess. In HF patients, both left ventricular end-diastolic and end-systolic volumes increased in response to high salt diet, whereas ejection fraction and stroke volume failed to increase, and total peripheral resistance did not change during high salt diet. In addition, plasma ANF levels did not rise in HF in response to salt loading, whereas plasma renin activity and aldosterone concentrations were as much suppressed as in normals. Although urinary sodium excretions were not significantly different in the two groups, there was a small but systematic reduction of daily sodium excretion in HF, which resulted in a significantly higher cumulative sodium balance in HF than in normals during the high salt diet period (P < .001).
CONCLUSIONS: These results show a reduced ability to excrete a sodium load and early abnormalities of cardiac and hemodynamic adaptations to salt excess in patients with mild heart failure and no signs or symptoms of congestion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403308     DOI: 10.1161/01.cir.88.4.1620

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

1.  Congestive heart failure: where homeostasis begets dyshomeostasis.

Authors:  German Kamalov; Syamal K Bhattacharya; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

2.  Comparing Sodium Intake Strategies in Heart Failure: Rationale and Design of the Prevent Adverse Outcomes in Heart Failure by Limiting Sodium (PROHIBIT) Study.

Authors:  Javed Butler; Lampros Papadimitriou; Vasiliki Georgiopoulou; Hal Skopicki; Sandra Dunbar; Andreas Kalogeropoulos
Journal:  Circ Heart Fail       Date:  2015-05       Impact factor: 8.790

3.  Acetazolamide as a potent chloride-regaining diuretic: short- and long-term effects, and its pharmacologic role under the 'chloride theory' for heart failure pathophysiology.

Authors:  Hajime Kataoka
Journal:  Heart Vessels       Date:  2019-05-21       Impact factor: 2.037

4.  Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure.

Authors:  Wayne L Miller; Daniel D Borgeson; J Aaron Grantham; Andreas Luchner; Margaret M Redfield; John C Burnett
Journal:  Eur J Heart Fail       Date:  2015-02       Impact factor: 15.534

5.  Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction.

Authors:  Paul M McKie; John A Schirger; Lisa C Costello-Boerrigter; Sherry L Benike; Lynn K Harstad; Kent R Bailey; David O Hodge; Margaret M Redfield; Robert D Simari; John C Burnett; Horng H Chen
Journal:  J Am Coll Cardiol       Date:  2011-11-08       Impact factor: 24.094

6.  How do changes in lifestyle complement medical treatment in heart failure?

Authors:  J Soler-Soler; G Permanyer-Miralda
Journal:  Br Heart J       Date:  1994-09

7.  Sodium restriction in heart failure: benefit or harm?

Authors:  Matthew C Konerman; Scott L Hummel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-02

8.  Changes of renal AQP2, ENaC, and NHE3 in experimentally induced heart failure: response to angiotensin II AT1 receptor blockade.

Authors:  Sophie C Lütken; Soo Wan Kim; Thomas Jonassen; David Marples; Mark A Knepper; Tae-Hwan Kwon; Jørgen Frøkiaer; Søren Nielsen
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

9.  Renal denervation improves sodium excretion in rats with chronic heart failure: effects on expression of renal ENaC and AQP2.

Authors:  Hong Zheng; Xuefei Liu; Kenichi Katsurada; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-06       Impact factor: 4.733

Review 10.  Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.

Authors:  Michael R Seawell; Fahed Al Darazi; Victor Farah; Kodangudi B Ramanathan; Kevin P Newman; Syamal K Bhattacharya; Karl T Weber
Journal:  Curr Heart Fail Rep       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.